drugset / Trial / NCT06236113

Low Dose Ketamine for Blunt Thoracic Trauma

NCT06236113 ↗

Phase 4 Completed 50 enrolled North Memorial Health Care
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this Randomized controlled double-blinded trial is to compare the addition of a ketamine infusion to placebo, when added to standard care in adult blunt trauma patients with multiple rib fractures. The main question it aims to answer are: • addition of low dose ketamine infusion (LDKI) decreases narcotic use • does LDKI impact pulmonary complications, readmission, or hospital length of stay Participants will receive usual standard of care with up to 48 hours of LDKI or placebo. If there is a comparison group: Researchers will compare infusion of a saline infusion to LDKI to see if LDKI decreases need for narcotic analgesics use.

Timeline

Start
2021-10-01
Primary completion
2023-03-19
Completion
2023-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.1 mg/kg Intravenous

Indications

No indication recorded.